| First hospital outbreak of the globally emerging Candida auris in a European hospital S Schelenz, F Hagen, JL Rhodes, A Abdolrasouli, A Chowdhary, A Hall, ... Antimicrobial Resistance & Infection Control 5, 1-7, 2016 | 768 | 2016 |
| Candida auris: a review of the literature A Jeffery-Smith, SK Taori, S Schelenz, K Jeffery, EM Johnson, A Borman, ... Clinical microbiology reviews 31 (1), 10.1128/cmr. 00029-17, 2018 | 601 | 2018 |
| Genomic epidemiology of the UK outbreak of the emerging human fungal pathogen Candida auris J Rhodes, A Abdolrasouli, RA Farrer, CA Cuomo, DM Aanensen, ... Emerging microbes & infections 7 (1), 1-12, 2018 | 242 | 2018 |
| A systematic review of the clinical, public health and cost-effectiveness of rapid diagnostic tests for the detection and identification of bacterial intestinal pathogens in … I Abubakar, L Irvine, CF Aldus, GM Wyatt, R Fordham, S Schelenz, ... Health technology assessment (Winchester, England) 11 (36), 1-216, 2007 | 217 | 2007 |
| British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases S Schelenz, RA Barnes, RC Barton, JR Cleverley, SB Lucas, CC Kibbler, ... The Lancet Infectious Diseases 15 (4), 461-474, 2015 | 213 | 2015 |
| Binding of host collectins to the pathogenic yeast Cryptococcus neoformans: human surfactant protein D acts as an agglutinin for acapsular yeast cells S Schelenz, R Malhotra, RB Sim, U Holmskov, GJ Bancroft Infection and immunity 63 (9), 3360-3366, 1995 | 177 | 1995 |
| Pseudomonas aeruginosa infection in cystic fibrosis: pathophysiological mechanisms and therapeutic approaches H Lund-Palau, AR Turnbull, A Bush, E Bardin, L Cameron, O Soren, ... Expert review of respiratory medicine 10 (6), 685-697, 2016 | 169 | 2016 |
| Insidious Risk of Severe Mycobacterium chimaera Infection in Cardiac Surgery Patients M Chand, T Lamagni, K Kranzer, J Hedge, G Moore, S Parks, S Collins, ... Clinical infectious diseases 64 (3), 335-342, 2017 | 164 | 2017 |
| Infective endocarditis in dialysis patients: new challenges and old T Doulton, N Sabharwal, HS Cairns, S Schelenz, S Eykyn, P O'Donnell, ... Kidney international 64 (2), 720-727, 2003 | 164 | 2003 |
| In vitro efficacy of disinfectants utilised for skin decolonisation and environmental decontamination during a hospital outbreak with Candida auris A Abdolrasouli, D Armstrong‐James, L Ryan, S Schelenz Mycoses 60 (11), 758-763, 2017 | 145 | 2017 |
| Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis D Armstrong-James, J Youngs, T Bicanic, A Abdolrasouli, DW Denning, ... European Respiratory Journal 56 (4), 2020 | 143 | 2020 |
| Epidemiology of oral yeast colonization and infection in patients with hematological malignancies, head neck and solid tumors S Schelenz, S Abdallah, G Gray, H Stubbings, I Gow, P Baker, PR Hunter Journal of oral pathology & medicine 40 (1), 83-89, 2011 | 136 | 2011 |
| An outbreak of multidrug-resistant Pseudomonas aeruginosa infection associated with contamination of bronchoscopes and an endoscope washer-disinfector S Schelenz, G French Journal of Hospital Infection 46 (1), 23-30, 2000 | 131 | 2000 |
| Cytokine and chemokine responses following pulmonary challenge with Aspergillus fumigatus: obligatory role of TNF-alpha and GM-CSF in neutrophil recruitment. S Schelenz, DA Smith, GJ Bancroft Medical mycology 37 (3), 183-194, 1999 | 129 | 1999 |
| First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control 5: 35 S Schelenz, F Hagen, JL Rhodes, A Abdolrasouli, A Chowdhary, A Hall, ... | 128 | 2016 |
| Population genomics confirms acquisition of drug-resistant Aspergillus fumigatus infection by humans from the environment J Rhodes, A Abdolrasouli, K Dunne, TR Sewell, Y Zhang, E Ballard, ... Nature microbiology 7 (5), 663-674, 2022 | 126 | 2022 |
| Management of candidiasis in the intensive care unit S Schelenz Journal of Antimicrobial Chemotherapy 61 (suppl_1), i31-i34, 2008 | 109 | 2008 |
| Yeasticidal activity of chemical disinfectants and antiseptics against Candida auris G Moore, S Schelenz, AM Borman, EM Johnson, CS Brown Journal of Hospital Infection 97 (4), 371-375, 2017 | 100 | 2017 |
| Control of Candida auris in healthcare institutions: Outcome of an International Society for Antimicrobial Chemotherapy expert meeting N Kenters, M Kiernan, A Chowdhary, DW Denning, J Pemán, K Saris, ... International journal of antimicrobial agents 54 (4), 400-406, 2019 | 96 | 2019 |
| Longitudinal surveillance of bacteraemia in haematology and oncology patients at a UK cancer centre and the impact of ciprofloxacin use on antimicrobial resistance S Schelenz, D Nwaka, PR Hunter Journal of Antimicrobial Chemotherapy 68 (6), 1431-1438, 2013 | 86 | 2013 |
Darius Armstrong-JamesClinical Professor, Imperial College LondonVerified email at imperial.ac.uk
